The <scp>pan‐JAK</scp> inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16‐week randomized phase <scp>IIb</scp> trial*-Reference-Cited by-同舟云学术

The pan‐JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16‐week randomized phase IIb trial*

Published:2022-04-19 Issue:1 Volume:187 Page:42-51
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Worm Margitta¹^ORCID,Thyssen Jacob P.²,Schliemann Sibylle³^ORCID,Bauer Andrea⁴,Shi Vivian Y.⁵,Ehst Ben⁶,Tillmann Sandra⁷,Korn Sofie⁷,Resen Katarina⁷,Agner Tove²^ORCID

Affiliation:

1. Allergologie und Immunologie, Klinik für Dermatologie, Venerologie und Allergologie, Campus Charité Mitte Universitätsmedizin Berlin Germany

2. Department of Dermatology and Venereology, Bispebjerg Hospital University of Copenhagen Denmark

3. Klinik für Hautkrankheiten Jena University Hospital Germany

4. Department of Dermatology University Allergy Center (UAC), University Hospital Carl Gustav Carus Germany

5. Department of Dermatology University of Arkansas for Medical Sciences Little Rock Arkansas USA

6. Oregon Medical Research Center Portland OR USA

7. LEO Pharma A/S Ballerup Denmark

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.21037

Reference33 articles.

1. Prevalence, incidence, and severity of hand eczema in the general population – A systematic review and meta‐analysis

2. Canadian Hand Dermatitis Management Guidelines

3. Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema

4. Current and emerging therapies for hand eczema

5. Guidelines for diagnosis, prevention and treatment of hand eczema

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Atopic Hand Dermatitis;Dermatologic Clinics;2024-10

2. Januskinaseinhibitoren für dermatologische Erkrankungen;Die Dermatologie;2024-08-30

3. Recent progress in tyrosine kinase 2 inhibitors for atopic dermatitis;Expert Opinion on Investigational Drugs;2024-08-21

4. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials;The Lancet;2024-08

5. Real-world Experience of Abrocitinib on Difficult-to-treat Hand Eczema in Chinese Patients;Acta Dermato-Venereologica;2024-06-08